RECORD-4: a multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC)

被引：0
|
作者：
Cosgriff, Thomas [1 ]
Alyasova, Anna [2 ]
Ye, Dingwei [3 ]
Xie, Liping [4 ]
Kurteva, Galina [5 ]
Kowalyszyn, Ruben [6 ]
Neron, Yeni [7 ]
Collins, Latonya [8 ]
Brechenmacher, Thomas [9 ]
Lin, Chinjune [8 ]
Morgan, Liza [8 ]
Yang, Lin [10 ]
Motzer, Robert [11 ]
机构：
[1] Crescent City Res Consortium, Metairie, LA USA
[2] Prevoljskiy Reg Med Ctr, Novgorod, Russia
[3] Fudan Univ, Shanghai Canc Ctr, Shanghai 200433, Peoples R China
[4] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Hangzhou, Zhejiang, Peoples R China
[5] Ctr Oncol, Sofia, Bulgaria
[6] Ctr Invest Clin Clin Viedma, Viedma, Argentina
[7] CEPON, Florianopolis, SC, Brazil
[8] Novartis Oncol, E Hanover, NJ USA
[9] Novartis Pharma SAS, Rueil Malmaison, France
[10] Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China
[11] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
BJU INTERNATIONAL | 2015年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：6 / 7
页数：2
相关论文
共 50 条
  • [1] RECORD-4: A multicenter, phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Motzer, Robert
    Alyasova, Anna
    Ye, Dingwei
    Karpenko, Andrey
    Li, Hanzhong
    Alekseev, Boris Y.
    Xie, Liping
    Kurteva, Galina Petrova
    Kowalyszyn, Ruben Dario
    Neron, Yeni
    Cosgriff, Thomas
    Collins, LaTonya
    Brechenmacher, Thomas
    Segal, Scott
    Morgan, Liza M.
    Yang, Lin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [2] RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): anti-vegf cohort subanalysis
    Cosgriff, Thomas
    Yang, Lin
    Alyasova, Anna
    Ye, Dingwei
    Karpenko, Andrey
    Alekseev, Boris
    Kowalyszyn, Ruben
    Karyakin, Oleg
    Neron, Yeni
    Collins, La T.
    Brechenmacher, Thomas
    Lin, Chinjune
    Morgan, Liza
    Motzer, Robert
    [J]. BJU INTERNATIONAL, 2016, 118 : 23 - 24
  • [3] RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients with metastatic renal cell carcinoma (mRCC): anti-VEGF cohort subanalysis
    Cosgriff, Thomas
    Yang, Lin
    Alyasova, Anna
    Ye, Dingwei
    Karpenko, Andrey
    Alekseev, Boris
    Kowalyszyn, Ruben
    Karyakin, Oleg
    Neron, Yeni
    Collins, La T.
    Brechenmacher, Thomas
    Lin, Chinjune
    Morgan, Liza
    Motzer, Robert
    [J]. BJU INTERNATIONAL, 2016, 118 : 18 - 19
  • [4] RECORD-4 phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Final OS analysis.
    Cosgriff, Thomas
    Yang, Lin
    Alyasova, Anna
    Ye, Dingwei
    Karpenko, Andrey
    Li, Hanzhong
    Alekseev, Boris
    Xie, Li-ping
    Kowalyszyn, Ruben Dario
    Karyakin, Oleg
    Neron, Yeni Veronica
    Collins, LaTonya
    Brechenmacher, Thomas
    Lin, Chinjune
    Morgan, Liza
    Motzer, Robert J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [5] RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Pooled anti-VEGF cohort subanalysis
    Alekseev, B.
    Yang, L.
    Alyasova, A.
    Ye, D.
    Karpenko, A.
    Li, H.
    Xie, L.
    Kurteva, G.
    Kowalyszyn, R.
    Karyakin, O.
    Neron, Y.
    Cosgriff, T.
    Collins, L.
    Brechenmacher, T.
    Lin, J.
    Morgan, L.
    Motzer, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S518 - S519
  • [6] Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4)
    Motzer, R. J.
    Alyasova, A.
    Ye, D.
    Karpenko, A.
    Li, H.
    Alekseev, B.
    Xie, L.
    Kurteva, G.
    Kowalyszyn, R.
    Karyakin, O.
    Neron, Y.
    Cosgriff, T.
    Collins, L.
    Brechenmacher, T.
    Lin, C.
    Morgan, L.
    Yang, L.
    [J]. ANNALS OF ONCOLOGY, 2016, 27 (03) : 441 - 448
  • [7] RECORD-4: Multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis
    Yang, L.
    Alyasova, A.
    Ye, D.
    Karpenko, A.
    Li, H.
    Alekseev, B.
    Xie, L.
    Kurteva, G.
    Kowalyszyn, R. D.
    Karyakin, O.
    Neron, Y. V.
    Cosgriff, T. M.
    Collins, L.
    Brechenmacher, T.
    Lin, J. C.
    Morgan, L.
    Motzer, R.
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 72 - 72
  • [8] RECORD-4 multicenter phase II trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Anti-VEGF cohort subanalysis.
    Cosgriff, Thomas
    Yang, Lin
    Alyasova, Anna
    Ye, Dingwei
    Karpenko, Andrey
    Li, Hanzhong
    Alekseev, Boris
    Xie, Li-ping
    Kowalyszyn, Ruben Dario
    Karyakin, Oleg
    Neron, Yeni Veronica
    Collins, LaTonya
    Brechenmacher, Thomas
    Lin, Chinjune
    Morgan, Liza
    Motzer, Robert J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [9] RECORD-4 multicenter phase 2 trial of second-line everolimus (EVE) in patients (pts) with metastatic renal cell carcinoma (mRCC): Asian versus non-Asian population subanalysis
    Yang, L.
    Alyasova, A.
    Ye, D.
    Karpenko, A.
    Li, H.
    Alekseev, B.
    Xie, L.
    Kurteva, G.
    Kowalyszyn, R.
    Karyakin, O.
    Neron, Y.
    Cosgriff, T.
    Collins, L.
    Brechenmacher, T.
    Lin, J.
    Morgan, L.
    Motzer, R.
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 : S524 - S524
  • [10] RECORD-4 multicenter phase 2 trial of second-line everolimus in patients with metastatic renal cell carcinoma: Asian versus non-Asian population subanalysis
    Yang, Lin
    Alyasova, Anna
    Ye, Dingwei
    Ridolfi, Antonia
    Dezzani, Luca
    Motzer, Robert J.
    [J]. BMC CANCER, 2018, 18
12345